(1S,3aS,4S,7S)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene

Details

Top
Internal ID 5d282791-32f6-439c-9c08-65fa9128dc85
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (1S,3aS,4S,7S)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene
SMILES (Canonical) CC1CCC(C=C2C1CCC2C)C(=C)C
SMILES (Isomeric) C[C@H]1CC[C@@H](C=C2[C@H]1CC[C@@H]2C)C(=C)C
InChI InChI=1S/C15H24/c1-10(2)13-7-5-11(3)14-8-6-12(4)15(14)9-13/h9,11-14H,1,5-8H2,2-4H3/t11-,12-,13-,14-/m0/s1
InChI Key DUYRYUZIBGFLDD-XUXIUFHCSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 5.30
Atomic LogP (AlogP) 4.58
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
DUYRYUZIBGFLDD-XUXIUFHCSA-N

2D Structure

Top
2D Structure of (1S,3aS,4S,7S)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9926 99.26%
Caco-2 + 0.9265 92.65%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Lysosomes 0.7069 70.69%
OATP2B1 inhibitior - 0.8487 84.87%
OATP1B1 inhibitior + 0.9094 90.94%
OATP1B3 inhibitior + 0.9551 95.51%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior - 0.9146 91.46%
P-glycoprotein inhibitior - 0.9277 92.77%
P-glycoprotein substrate - 0.7422 74.22%
CYP3A4 substrate - 0.5620 56.20%
CYP2C9 substrate - 0.7977 79.77%
CYP2D6 substrate - 0.6973 69.73%
CYP3A4 inhibition - 0.9414 94.14%
CYP2C9 inhibition - 0.7636 76.36%
CYP2C19 inhibition - 0.7457 74.57%
CYP2D6 inhibition - 0.9171 91.71%
CYP1A2 inhibition - 0.5965 59.65%
CYP2C8 inhibition - 0.8222 82.22%
CYP inhibitory promiscuity - 0.7944 79.44%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7600 76.00%
Carcinogenicity (trinary) Non-required 0.4450 44.50%
Eye corrosion - 0.8060 80.60%
Eye irritation + 0.7900 79.00%
Skin irritation + 0.5756 57.56%
Skin corrosion - 0.9706 97.06%
Ames mutagenesis - 0.7200 72.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4240 42.40%
Micronuclear - 0.9900 99.00%
Hepatotoxicity + 0.6575 65.75%
skin sensitisation + 0.7987 79.87%
Respiratory toxicity - 0.8111 81.11%
Reproductive toxicity - 0.7333 73.33%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.6056 60.56%
Acute Oral Toxicity (c) III 0.8608 86.08%
Estrogen receptor binding - 0.9304 93.04%
Androgen receptor binding - 0.8540 85.40%
Thyroid receptor binding - 0.6947 69.47%
Glucocorticoid receptor binding - 0.7469 74.69%
Aromatase binding - 0.8176 81.76%
PPAR gamma - 0.8629 86.29%
Honey bee toxicity - 0.9244 92.44%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9974 99.74%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.41% 91.11%
CHEMBL4040 P28482 MAP kinase ERK2 87.53% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.07% 96.09%
CHEMBL241 Q14432 Phosphodiesterase 3A 83.71% 92.94%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.98% 97.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.24% 97.25%

Cross-Links

Top
PubChem 91748784
NPASS NPC260756